Idexx Labs (IDXX) Tops Q4 EPS by 1c; Raises Lower-End of FY12 EPS Outlook

Idexx Labs (NASDAQ: IDXX) reported Q4 EPS of $0.64, $0.01 better than the analyst estimate of $0.63. Revenue for the quarter came in at $307.2 million versus the consensus estimate of $303.97 million.

Idexx Labs sees FY2012 EPS of $3.04-$3.10, versus prior guidance of $3.00-$3.10 and the consensus of $3.07. Sees FY2012 revenue of $1.30-$1.31 billion, versus the consensus of $1.30 billion.

For earnings history and earnings-related data on Idexx Labs (IDXX) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Goldman Sachs Downgrades Norsk Hydro SA (NHY:NO) (NHYDY) to Neutral
• Caldwell sells IQTalent subsidiary to WinMil for C$4.7M
• BioNTech and Bristol Myers Squibb report Phase 2 data for pumitamig in NSCLC